Eli Lilly Raises Full-Year Forecast
Photo: Darron Cummings/AP/TT

Eli Lilly Raises Full-Year Forecast After Beating Profit and Sales Expectations

The American pharmaceutical giant Eli Lilly, Danish Novo's main competitor, is beating profit expectations and raising its forecast for the year.

Advertisement

The stock rose almost 6 percent in futures trading on Wall Street after Eli Lilly released its quarterly report.

Eli Lilly expects revenue of $91-92 billion this year, up from its previous forecast of $85-87 billion.

For the third quarter, Eli Lilly reported earnings of $7.48 per share, compared with $7.02 per share in the same quarter last year and an average forecast of $5.59 per share, according to Bloomberg.

Sales rose 39 percent to $24.4 billion, compared with expectations of $22.5 billion.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All